Integrative Proteomics and Metabololmics for Pediatric Glomerula Disease Biomarkers

Grants and Contracts Details


HUMAN CLINICAL TRIAL Glomerular disease, including minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), membranous nephropathy (MN), and immunoglobulin A nephropathy (IgAN), often share a common clinical presentation. These chronic diseases, affecting both children and adults, produce proteinuria, hypoalbuminemia, hematuria, and/or edema, as the glomerulus is damaged by the underlying disease process. Progressive loss of kidney function often occurs over many months or years and results in substantial individual and societal burden.
Effective start/end date7/2/185/31/19


  • Research Institute at Nationwide Childrens Hospital: $21,960.00


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.